Bioresus

Bioresus is an Australian biotechnology company focused on developing innovative resuscitation and organ preservation therapies. The company's core technology, the ALM (Adenosine, Lidocaine, and Magnesium) solution, is designed to stabilize patients during critical care scenarios such as hemorrhagic shock, sepsis, and traumatic brain injury. By modulating the body's response to extreme stress and inflammation, Bioresus aims to extend the golden hour for trauma victims and improve outcomes in emergency medicine. Their pipeline includes applications for both military and civilian trauma care, as well as solutions for extending the viability of donor organs.